---
document_datetime: 2023-09-21 18:11:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/combivir-epar-all-authorised-presentations_en.pdf
document_name: combivir-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.730422
conversion_datetime: 2025-12-19 12:06:46.310377
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Tradename   | Strength                            | Pharmaceutical Form   | Route of administration   | Packaging         |   Package size |
|-----------------|-------------|-------------------------------------|-----------------------|---------------------------|-------------------|----------------|
| EU/1/98/058/001 | Combivir    | 150 mg lamivudine 300 mg zidovudine | Film-coated tablets   | Oral use                  | Blister (PVC/alu) |             60 |
| EU/1/98/058/002 | Combivir    | 150 mg lamivudine 300 mg zidovudine | Film-coated tablets   | Oral use                  | Bottle (HDPE)     |             60 |